Ratings by Brookline Capital Markets
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Leah RUsh Cann | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
106.00 (N/A) |
|
Details | |
| 2/23/2026 | Leah Rush Cann | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
30.00 (20.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 289 more... | |||||||||
